Article
Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA.
Antimicrobial agents and chemotherapy - 1 Dec 2001
Montero C, Mateu G, Rodriguez R, Takiff H
Abstract excerpt
The fluoroquinolones (FQ) are used in the treatment of Mycobacterium tuberculosis, but the development of resistance could limit their effectiveness. FQ resistance (FQ(R)) is a multistep process involving alterations in the type II topoisomerases and perhaps in the regulation of efflux pumps, but several of the steps remain unidentified. Recombinant plasmid pGADIV was selected from a genomic library of wild-type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
